PRECLINICAL ASSETS MARKET ANALYSIS

Preclinical Assets Market, by Service ( Bioanalysis and DMPK studies  (In vitro, In-vivo), Toxicology Testing (GLP, Non-GLP), compound management (Process R&D, Custom Synthesis, Asymmetric Synthesis & Others (Scale-up, cGMP, etc.), Safety Pharmacology, Others(Chemistry, etc.)), by Model type (Patient Derived Organoid (PDO) Model, Patient derived xenograft model), by End user (Biopharmaceutical Companies, Government Institutes &  Others (Academic and Research institutes) ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

• Published In : Nov 2022
• Code : CMI5326
• Pages :176
• Formats :
    Excel and PDF
• Industry : Pharmaceutical